Status:
UNKNOWN
Evaluation of ESMO Guidelines Applicability and Adherence in Cancer Pain Management in the Palliative Care Setting
Lead Sponsor:
Antea Foundation
Collaborating Sponsors:
Istituto Di Ricerche Farmacologiche Mario Negri
Conditions:
Cancer Pain
Pain
Eligibility:
All Genders
18+ years
Brief Summary
Palliative care (PC) is focused on improving the Quality of Life (QoL) of patients living with a life-threatening illness. Each year, an estimated 40 million people need PC management in the world. In...
Eligibility Criteria
Inclusion
- age \>18 years;
- cancer diagnosis;
- patient enrolled within 48h from admission in PC;
- presence of pain with or without analgesic therapy or absence of pain being already on ATC analgesic therapy;
- life expectancy longer than two weeks;
- written patient informed consent.
Exclusion
- diagnosis of primary brain tumor or leukemia (acute or chronic);
- clinical conditions that, at Investigator evaluation, prevent the follow up visits;
- absence of pain without analgesic therapy.
Key Trial Info
Start Date :
January 7 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 7 2022
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04795739
Start Date
January 7 2021
End Date
April 7 2022
Last Update
June 21 2021
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospice Alba Chiara
Lanciano, Chieti, Italy
2
Hospice Torrevecchia Teatina
Torrevecchia Teatina, Chieti, Italy
3
Hospice "La Torre sul Colle"
Spoleto, Perugia, Italy
4
Hospice Carlo Chenis
Civitavecchia, Roma, Italy